[RESEARCH HIGHLIGHTS]
| RESEARCH HIGHLIGHTS |
Genetic changes in cancer cells, such as these pancreatic cancer cells, will be much easier to track thanks to a new DNA analysis method developed by A*STAR researchers.
Cancer genetics REVEALING THE BLUEPRINTS
A SENSITIVE DNA PROFILING TECHNIQUE COULD IMPROVE SCIENTISTS’ APPROACH TO FIGHTING CANCER DRUG RESISTANCE
A method for analyzing DNA in cells at a deeper level is set to give a clearer picture of the biology of tumors and could revolutionize the way they are treated. Cancer claims millions of lives every year
and researchers are racing to find effective treatments. However, no two cancers are the same, and drugs that are effective for one patient may not work for another. A reason is that tumors contain millions of
cells which all have slightly different charac- teristics. Understanding the subtle differences between cancer cells could shed light on how they evolve and reveal which treatment is most likely to be effective. In 2013, Lih Feng Cheow and his colleagues
from the A*STAR Institute of Molecular and Cell Biology developed a method for identifying
www.astar-research.com
some of these differences, by measuring a cell signature called DNA methylation in single cells. After writing new scripts for a system that is
already used commercially to sequence DNA, Cheow and his team have automated their method to run on microchips that can treat and analyse 96 cells at the same time1. They also expanded the method to measure even more cellular detail — DNA mutation and gene expression — concurrently. The team tested their method to better
understand a type of lung cancer called adenocarcinoma. Using their technique, they could distinguish
previously undiscovered signatures. They found that the subset of cells in the population that carried a key cancer mutation exhibited distinct patterns of DNA methylation.
The benefit of this method is that it is
user-friendly, says Cheow. “We reengineered a commercial system so that anyone can just get this off the shelf.” After demonstrating the method works, Cheow says, “we’re now working with clinicians to look at the profiles of different cancer cells and to look at drug resistance.” Cheow believes his method may also find
use in clinical laboratories, where it could be used to screen embryos and increase the suc- cess rates of in vitro fertilization procedures. “We want anyone to have easy access to
this method and to do great science with it,” he says.
1. Cheow, L. F., Courtois, E. T., Tan, Y. et al. Single-cell multimodal profiling reveals cellular epigenetic heterogeneity. Nature Methods 13, 833–836 (2016).
A*STAR RESEARCH 15
© Stocktrek Images/Getty
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
